These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25654085)

  • 1. HFE genotyping in patients with elevated serum iron indices and liver diseases.
    Evangelista AS; Nakhle MC; de Araújo TF; Abrantes-Lemos CP; Deguti MM; Carrilho FJ; Cançado EL
    Biomed Res Int; 2015; 2015():164671. PubMed ID: 25654085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
    Aranda N; Viteri FE; Montserrat C; Arija V
    Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
    Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
    Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant HFE genotype leads to significant iron overload in patients with liver diseases from western Romania.
    Neghina AM; Anghel A; Sporea I; Popescu A; Neghina R; Collins A; Thorstensen K
    J Appl Genet; 2009; 50(2):173-6. PubMed ID: 19433916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism.
    Gómez-Llorente C; Miranda-León MT; Blanco S; Gandia-Pla S; Gómez-Capilla JA; Fárez-Vidal ME
    Ann Hematol; 2005 Oct; 84(10):650-5. PubMed ID: 15986199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
    Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
    Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron loading in patients with compound heterozygous HFE mutations.
    Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP
    Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HFE gene mutations in patients with primary iron overload: is there a significant improvement in molecular diagnosis yield with HFE sequencing?
    Santos PC; Pereira AC; Cançado RD; Schettert IT; Sobreira TJ; Oliveira PS; Hirata RD; Hirata MH; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2010 Dec; 45(4):302-7. PubMed ID: 20843714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
    Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy.
    Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M
    Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using iron studies to predict HFE mutations in New Zealand: implications for laboratory testing.
    O'Toole R; Romeril K; Bromhead C
    Intern Med J; 2017 Apr; 47(4):447-454. PubMed ID: 28019068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.